BridgeBio Oncology Therapeutics, Inc
Fundamentals
Oldest to newest| Line | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating income | −$41,692 | −$80.9M | −$145.8M |
| Net income | −$41,692 | −$74.3M | −$134.0M |
| Operating cash flow | none on file | −$55.0M | −$113.9M |
| Free cash flow | none on file | −$55.1M | −$114.5M |
| Cash | $250,000 | $30.9M | $373.7M |
| Shares outstanding | none on file | 28.4K | 80.0M |